Xiao Feng, Fei Min, Cheng Chun, Ji Yuhong, Sun Linlin, Qin Jing, Yang Junling, Liu Yonghua, Zhang Li, Xia Yinyin, Shen Aiguo
The Jiangsu Province Key Laboratory of Neuroregeneration, Nantong University, Nantong, 226001, People's Republic of China.
Neurochem Res. 2008 Sep;33(9):1735-48. doi: 10.1007/s11064-008-9617-9. Epub 2008 Feb 29.
Src suppressed C kinase substrate (SSeCKS) was identified as a PKC substrate/PKC-binding protein, which plays a role in mitogenic regulatory activity and has a function in the control of cell signaling and cytoskeletal arrangement. However its distribution and function in the central nervous system (CNS) lesion remain unclear. In this study, we mainly investigated the mRNA and protein expression and cellular localization of SSeCKS during spinal cord injury (SCI). Real-time PCR and Western blot analysis revealed that SSeCKS was present in normal whole spinal cord. It gradually increased, reached a peak at 3 days for its mRNA level and 5 days for its protein level after SCI, and then declined during the following days. In ventral horn, the expression of SSeCKS underwent a temporal pattern that was similar with the whole spinal cord in both mRNA and protein level. However, in dorsal horn, the mRNA and protein for SSeCKS expression were significantly increased at 1 day for its mRNA level and 3 days for its protein level, and then gradually declined to the baseline level, ultimately up-regulated again from 7 to 14 days. The protein expression of SSeCKS was further analysed by immunohistochemistry. The positively stained areas for SSeCKS changed with the similar pattern to that of protein expression detected by immunoblotting analysis. Double immunofluorescence staining showed that SSeCKS immunoreactivity (IR) was found in neurons, astrocytes, oligodendrocytes of spinal cord tissues within 5 mm from the lesion site. Importantly, injury-induced expression of SSeCKS was co-labeled by active caspase-3 (apoptotic marker), Tau-1 (the marker for pathological oligodendrocyte) and beta-1,4-galactosyltransferase 1 (GalT). All the results suggested that SSeCKS might play important roles in spinal cord pathophysiology and further research is needed to have a good understanding of its function and mechanism.
Src 抑制性 C 激酶底物(SSeCKS)被鉴定为一种蛋白激酶 C(PKC)底物/PKC 结合蛋白,它在促有丝分裂调节活性中发挥作用,并且在细胞信号传导和细胞骨架排列的控制中具有功能。然而,其在中枢神经系统(CNS)损伤中的分布和功能仍不清楚。在本研究中,我们主要研究了脊髓损伤(SCI)过程中 SSeCKS 的 mRNA 和蛋白表达以及细胞定位。实时 PCR 和 Western 印迹分析显示,SSeCKS 存在于正常的整个脊髓中。SCI 后,它逐渐增加,其 mRNA 水平在 3 天达到峰值,蛋白水平在 5 天达到峰值,然后在接下来的几天下降。在腹角,SSeCKS 的表达在 mRNA 和蛋白水平上呈现出与整个脊髓相似的时间模式。然而,在背角,SSeCKS 表达的 mRNA 水平在 1 天显著增加,蛋白水平在 3 天显著增加,然后逐渐下降至基线水平,最终在 7 至 14 天再次上调。通过免疫组织化学进一步分析了 SSeCKS 的蛋白表达。SSeCKS 的阳性染色区域变化模式与免疫印迹分析检测到的蛋白表达模式相似。双重免疫荧光染色显示,在距损伤部位 5 毫米内的脊髓组织的神经元、星形胶质细胞、少突胶质细胞中发现了 SSeCKS 免疫反应性(IR)。重要的是,损伤诱导的 SSeCKS 表达与活性半胱天冬酶 -3(凋亡标志物)、Tau-1(病理性少突胶质细胞标志物)和β-1,4-半乳糖基转移酶 1(GalT)共同标记。所有结果表明 SSeCKS 可能在脊髓病理生理学中发挥重要作用,需要进一步研究以充分了解其功能和机制。